Clinical Trials Directory

Trials / Unknown

UnknownNCT05368896

Peri-operative Inflammaging in the Elderly After Surgery

Peri-OPerative InflamMAGing in Elderly Patients Undergoing Major Surgery: Prediction and Pathomechanisms of Post-operative Morbidities

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University of Bonn · Academic / Other
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

The population older than 80 years will significantly increase in the near future. Older patients' cognitive and physical status is known to deteriorate after surgery, leading to a high 30-day mortality due to post-operative comorbidities. Aging and related diseases share immune-related pathomechanisms. During aging, a chronic, low-grade sterile inflammation, called inflamaging, gradually develops. This likely results from low-grade innate immune activation and a functional, epigenomic and transcriptomic reprogramming of immune cells. Based on the hypothesis that surgical trauma leads to misplaced or altered self-molecules, which exacerbate inflammation and the postoperative risk for morbidity and mortality in elderly patients. There is increasing evidence that the individual's pre-operative immunobiography determines the susceptibility to peri-operative inflammation and post-operative outcome. Current exploratory pilot study will thus perform phenotyping of patients above 80 years undergoing major surgery. Participants will be evaluated for acute and long-term outcomes, including all-cause mortality, physical and cognitive function. To assess the individual's immunobiography, participants will be characterised by inflammation biomarkers combined with immunophenotyping, functional assays, and (epi-) genomic analyses before and after surgery. The cognitive impairment will be evaluated by measuring markers of neurodegeneration and neuropsychiatric testing and relate findings to volumetric imaging using high-resolution MRI to identify brain changes associated with cognitive decline.

Conditions

Timeline

Start date
2022-12-01
Primary completion
2024-12-30
Completion
2025-03-30
First posted
2022-05-10
Last updated
2023-02-28

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05368896. Inclusion in this directory is not an endorsement.